EA201800375A1 - METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING TOBRAMICIN, A PHARMACEUTICAL COMPOSITION CONTAINING TOBRAMICIN AND A MEDICINAL PRODUCT - Google Patents
METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING TOBRAMICIN, A PHARMACEUTICAL COMPOSITION CONTAINING TOBRAMICIN AND A MEDICINAL PRODUCTInfo
- Publication number
- EA201800375A1 EA201800375A1 EA201800375A EA201800375A EA201800375A1 EA 201800375 A1 EA201800375 A1 EA 201800375A1 EA 201800375 A EA201800375 A EA 201800375A EA 201800375 A EA201800375 A EA 201800375A EA 201800375 A1 EA201800375 A1 EA 201800375A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutical composition
- composition containing
- tobramicin
- producing
- medicinal product
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 title abstract 3
- 229960000707 tobramycin Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
В заявке описан способ получения фармацевтической композиции, содержащей в качестве действующего вещества тобрамицин, в форме раствора для ингаляции. Раствор дозируют в ампулы. Предложенный способ обеспечивает получение фармацевтической композиции с высокой стабильностью при температуре до 25°С и низким содержанием родственных примесей.The application describes a method for producing a pharmaceutical composition containing tobramycin as an active substance in the form of a solution for inhalation. The solution is dosed in ampoules. The proposed method provides a pharmaceutical composition with high stability at temperatures up to 25 ° C and a low content of related impurities.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EA201800375A EA201800375A1 (en) | 2018-07-13 | 2018-07-13 | METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING TOBRAMICIN, A PHARMACEUTICAL COMPOSITION CONTAINING TOBRAMICIN AND A MEDICINAL PRODUCT |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EA201800375A EA201800375A1 (en) | 2018-07-13 | 2018-07-13 | METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING TOBRAMICIN, A PHARMACEUTICAL COMPOSITION CONTAINING TOBRAMICIN AND A MEDICINAL PRODUCT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201800375A1 true EA201800375A1 (en) | 2020-01-31 |
Family
ID=69374445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201800375A EA201800375A1 (en) | 2018-07-13 | 2018-07-13 | METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING TOBRAMICIN, A PHARMACEUTICAL COMPOSITION CONTAINING TOBRAMICIN AND A MEDICINAL PRODUCT |
Country Status (1)
| Country | Link |
|---|---|
| EA (1) | EA201800375A1 (en) |
-
2018
- 2018-07-13 EA EA201800375A patent/EA201800375A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201790989A1 (en) | STABLE PREPARATION OF PROTEIN SOLUTION CONTAINING ANTI-VEGF ANTIBODY IN HIGH CONCENTRATION | |
| BR112014009131A8 (en) | meglumine stabilized etanercept formulations | |
| MX2014011122A (en) | STABILIZING COMPOSITION FOR BIOLOGICAL MATERIALS. | |
| MX363457B (en) | Substituted heterocyclic sulfonamide compounds useful as trpa1 modulators. | |
| EA201591003A1 (en) | DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION | |
| BR112015000229A2 (en) | stable aqueous formulations of etanercept | |
| EA202091755A1 (en) | HYALURONIC ACID COMPOSITIONS INCLUDING MEPIVACAINE | |
| EA201591618A1 (en) | SUBSTITUTED IMIDAZOPIRIDAZINES | |
| PH12019500467A1 (en) | Benzo-fused heterocyclic derivatives useful agonists of gpr120 | |
| BR112015026053A2 (en) | pharmaceutical composition, sealed container, metered dose inhaler, and methods for treating a patient suffering or susceptible to a respiratory disorder and for manufacturing a pharmaceutical composition | |
| EA201990550A1 (en) | OPHTHALMIC DRUG INCLUDING THE ASOLIC COMPOUND | |
| MX2020014262A (en) | Pharmaceutical composition containing poorly-soluble basic medicine. | |
| EA201800375A1 (en) | METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING TOBRAMICIN, A PHARMACEUTICAL COMPOSITION CONTAINING TOBRAMICIN AND A MEDICINAL PRODUCT | |
| EA201592297A1 (en) | AGOMELATIN COMPOSITIONS CONTAINING AGOMELATIN IN THE FORM OF CRYSTALS | |
| EA202090788A1 (en) | LIQUID COMPOSITION FOR USE AS ANTI-INFLAMMATORY PRODUCT | |
| EA202091561A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE LENALIDOMIDE SALT | |
| EA201890789A1 (en) | CONTAINING ZINEOL COMPOSITION FOR THE TREATMENT OF NOSE DISEASES | |
| EA201800311A1 (en) | METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION CONTAINING BORTEZOMIB, PRODUCT METHOD | |
| PH12017500323A1 (en) | P38 map kinase inhibiting indanyl urea compounds | |
| RU2012129783A (en) | METHOD FOR PRODUCING HIGHLY DISPERSED FORMS OF MEDICINES AND PHARMACEUTICAL COMPOSITIONS | |
| UY37426A (en) | METHOD FOR PRODUCING A PHARMACEUTICALLY STABLE COMPOSITION PRESENTED AS A WATER SOLUTION | |
| EA201800360A1 (en) | METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION CONTAINING BENDAMUSTINE, PHARMACEUTICAL COMPOSITION OF BENDAMUSTIN | |
| AR102572A1 (en) | FORMULATION OF STABLE PROTEIN SOLUTION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY | |
| AR130115A2 (en) | STABLE PROTEIN SOLUTION FORMULATION CONTAINING A HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY | |
| PL404379A1 (en) | Ointment |